Company type
Develops fully human therapeutic monoclonal antibody (mAb)Funding rounds
Series A
( )
Investor | Profile | Country | |
---|---|---|---|
![]() |
Novartis Venture Funds | The corporate venturing arm of Novartis. |
Investor | Profile | Country | |
---|---|---|---|
![]() |
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
Investment activity status
Active investor